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Prevotella species, members of the human microbiota, can cause opportunistic infections. Rapid and
accurate identiﬁcation of Prevotella isolates plays a critical role in successful treatment, especially since
the antibiotic susceptibility proﬁle differs between species. Studies, mostly carried out using the Matrix
Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Biotyper sys-
tem, showed that MALDI-TOF MS is an accurate, rapid and satisfactory method for the identiﬁcation of
clinically important anaerobes. In this multi-center study, we assessed the performance of the MALDI-
TOF MS VITEK MS system for the identiﬁcation of clinical Prevotella isolates. A total of 508 Prevotella
isolates, representing 19 different species, collected from 11 European countries, Kuwait and Turkey
between January 2014 and April 2016, were identiﬁed using VITEK MS (v3.0). The reliability of the
identiﬁcation was assessed by 16S rRNA gene sequencing. Using VITEK MS, 422 (83.1%) of the 508 isolates
were identiﬁed on the species level, 459 (90.4%) on the genus level. A total of 49 (9.6%) isolates were not
identiﬁed correctly. 16S rRNA gene sequencing results showed that this was partly due to the fact that
several species were not represented in the database. However, some species that were represented in
the database were also not identiﬁed. Five Prevotella strains were misidentiﬁed at the genus level, 2 of
these strains belonged to a species not represented in the database. In general, the VITEK MS offers a
reliable and rapid identiﬁcation of Prevotella species, however the databases needs to be expanded.
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Prevotella species are part of the oral, upper respiratory, intes-
tinal and female genital tract commensal microbiota. However,
they can also cause opportunistic infections, including speciﬁc oral
infections [1]. As for other anaerobic genera, the phenotypic iden-
tiﬁcation of Prevotella species is cumbersome and not always ac-
curate [2]. Nucleic acid sequencing methods are applied in order to
reach reliable identiﬁcations. However, these methods are expen-
sive, technically complex and too labor intensive for routineass spectrometric identiﬁcation of clinical Prevotella species using the
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The introduction of Matrix Assisted Laser Desorption Ionization
Time-of-Flight Mass Spectrometry (MALDI-TOF MS) had a revolu-
tionary impact on the identiﬁcation of anaerobic bacteria. It was
shown to be faster, cheaper and more reliable than traditional
methods [4e8]. Currently, two MALDI-TOF MS systems are
commercially available for routine use: theMALDI-TOFMS Biotyper
(Bruker Daltonics Inc., Germany) and VITEK MS (bioMerieux Inc.,
France). Although the methodology is similar, there are deﬁnitive
differences between the two systems in terms of the database
composition and the application of software packages for data
analysis [9].
Recently, taxonomic changes have been made to the Prevotella
genus and new species have been added, extended to now include
50 validated species (http://www.bacterio.net/prevotella.html)
[10,11]. The antibiotic susceptibility proﬁle differs between the
species [1,12]. Signiﬁcant interspecies differences in antimicrobial
resistance were observed for penicillin, clindamycin metronidazole
and tetracycline. It has been reported that P. bivia, Prevotella species
most frequently isolated from clinical specimens, was the most
resistant species to these antimicrobial agents, and also included
multidrug resistant strains [13]. Therefore, it is important that
clinical isolates are correctly identiﬁed at the species level, in order
to make successful treatment possible.
Studies, assessing the performance of MALDI-TOF MS for the
identiﬁcation of different Prevotella species, were mostly per-
formed using the MALDI-TOF MS Biotyper system [14,15]. The aim
of this multi-center study was to evaluate the performance of the
VITEK MS system for the identiﬁcation of clinically relevant Pre-
votella species. MALDI-TOF MS identiﬁcation results were
compared with 16S rRNA gene sequencing, which is considered the
reference method.
2. Methods
2.1. Bacterial isolates
A total of 508 non-duplicate Prevotella strains isolated from
different clinical samples of non-hospitalized or hospitalized pa-
tients were collected from 11 European countries [Austria (n¼ 29),
Belgium (n¼ 45), Croatia (n¼ 33), Denmark (n¼ 45), France
(n¼ 45), Germany (n¼ 34), Great Britain (n¼ 45), Greece (n¼ 18),
Hungary (n¼ 47), Netherlands (n¼ 45) and Slovenia (n¼ 29)],
Kuwait (n¼ 14) and Turkey (n¼ 79), between January 2014 and
April 2016. The strains were mainly isolated from abscesses (37.4%)
and wounds (18.1%). Other major categories of clinical samples
were from intraoral infections (17.4%), soft tissue (5.6%), and bone
biopsies (2.1%), non-blood sterile body ﬂuids (6.1%), and blood
(1.6%). Each laboratory identiﬁed its own isolates at the genus or
species level by using conventional and/or modern diagnostic tests
including MALDI-TOF MS (Biotyper MS, Bruker, Germany (9 coun-
tries) or VITEK MS, bioMerieux, France (3 countries)). The organ-
isms were sent to Turkey, in anaerobic transport medium
(Anaerobe systems, Morgan Hill, USA). Upon arrival the strains
were immediately cultured on Brucella Blood Agar (BBA) (Difco,
USA), supplemented with hemin and vitamin K. Viable strains were
stored at 80 C in 10% skimmed milk until use. The study was
carried out at the Department of Clinical Microbiology, School of
Medicine, Marmara University, Istanbul, Turkey.
2.2. Identiﬁcation by VITEK MS
All isolates were grown on BBA at 36 C for 48 h in an anaerobic
chamber (Bactron-I, SHELLAB, USA). The isolates were identiﬁed
according to the manufacturer's guidelines. Brieﬂy, a single colonyPlease cite this article in press as: N. Ulger Toprak, et al., Performance of m
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1 mL loop. The bacteria were covered with 1 mL of a-cyano-4-
hydroxycinnamic acid (HCCA) matrix solution (bioMerieux,
France). After drying at ambient temperature, the target slide was
inserted into the VITEK MS machine (bioMerieux, France). Micro-
bial identiﬁcation was performed by comparing the generated
spectra from the bacterial strains with the reference spectra pre-
sent in the VITEK MS version 3.0 database. The data were catego-
rized as follows: (I) accurate identiﬁcation at the species level; (II)
accurate identiﬁcation at the genus level, including multiple Pre-
votella species that have low discrimination; (III) misidentiﬁcation
(minor error; different Prevotella species, major error; different
genus) and (IV) no identiﬁcation.
Each bacterium was spotted twice on the same target slide. If a
good identiﬁcation was not obtained, the spot was reanalyzed. For
the misidentiﬁed or not-identiﬁed isolates, the test was repeated
three times.
2.3. 16S rRNA gene sequencing
The VITEK MS identiﬁcation was compared with the 16S rRNA
gene sequencing identiﬁcation. The bacterial DNA was extracted
using the Quick-gDNA™ MiniPrep Kit (Zymo Research, USA)
following the manufacturer's instructions. The 16S rRNA gene was
ampliﬁed by using the universal 8UA, 907B, 774A and 1485B
primers as described by Song et al. [16]. PCR products were
sequenced using an ABI prims 3100 genetic analyzer (Applied
Biosystems, Inc.) Sequences were analyzed using GenBank (www.
ncbi.nlm.nih.gov) [17]. Identiﬁcation at the species level was
considered reliable if the sequence similarity with its closest rela-
tive was 99% [18].
3. Results
All isolates were Gram-negative, coccoid and short bacilli. After
3e5 days incubation on BBA supplemented with hemin and
vitamin K, colonies vary from large to minute and were generally
circular, entire, convex and smooth. P. corporis, P. denticola, P.
intermedia, P. melaninogenica, P. nigrescens produce pigmented
colonies varying from light brown to black. The colonies of
P. nigrescens were also dry and brittle, it was hard to make a thin
smear on the slide. In non-pigmented organisms P. buccae had the
characteristic appearance of a mucoid colony.
Using 16S rRNA gene sequencing, all isolates were identiﬁed at
the species level, representing 19 different Prevotella species
(Table 1). The VITEK MS provided an accurate species identiﬁcation
for 422 (83.1%) of the isolates and an accurate genus identiﬁcation
for 459 (90.4%) of the isolates. The number of differences (n¼ 37)
between correct species identiﬁcation and genus identiﬁcation is
considered as a minor error, since species identiﬁcation was
incorrect and genus identiﬁcation correct. A major error was
encountered for 5 strains. Sequencing results showed that they
were members of the genus Prevotella, but VITEK MS identiﬁed
them to belong to the genera Porphyromonas, Peptostreptococcus,
Coronobacter and for two strains the results were a mix of different
genera (Table 2). Two of these strains belonged to Prevotella species
(P. bergensis and P. nanceiensis) not represented in the VITEK MS
database. Among the collection of all strains tested, 5 species were
encountered, which were not represented in the VITEK MS data-
base such as P. bergensis, P. conceptionensis, P. corporis, P. histicola
and P. nanceiensis. These species represented 43 isolates (Table 1).
Of these 43 isolates, 13 were correctly identiﬁed at the genus level,
28 were not identiﬁed and 2 strains were found to belong to a
different genus (as Porphyromonas asaccharolytica and Corono-
bacter sakazakii) (as mentioned above) (Tables 1 and 2). Theass spectrometric identiﬁcation of clinical Prevotella species using the
tps://doi.org/10.1016/j.anaerobe.2018.05.016
Table 1
Identiﬁcation of clinically relevant Prevotella isolates by the VITEK MS system.
Prevotella species Species Genus Misidentiﬁed NO ID (%) Number of main spectra
identiﬁed by sequencing Level (%) Level (%) Minor error (%) Major error (%)
P. baroniae (13) 11 (84.6) 12 (92.3) 1 (7.6) 0 (0.0) 1 (7.6) 1
P. bergensisa (13) 0 (0.0) 2 (15.4) 2 (15.3) 1 (7.6) 10 (76) 0
P. bivia (118) 117 (99.1) 118 (100) 1 (0.8) 0 (0.0) 0 (0.0) 8
P. buccae (68) 63 (92.6) 64 (94.1) 1 (1.1) 1 (1.1) 3 (4.4) 9
P. buccalis (4) 4 (100) 4 (100) 0 (0.0) 0 (0.0) 0 (0.0) 2
P. conceptionensisa (1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (100) 0
P. corporisa (5) 0 (0.0) 1 (20) 1 (20) 0 (0.0) 4 (80) 0
P. denticola (57) 52 (92.9) 56 (98.2) 4 (7) 0 (0.0) 1 (1.8) 6
P. disiens (31) 29 (93.5) 30 (96.7) 1 (3.2) 0 (0.0) 1 (3.2) 8
P. histicolaa (11) 0 (0.0) 8 (72.7) 8 (72.7) 0 (0.0) 3 (27.2) 0
P. intermedia (21) 17 (80.9) 19 (90.5) 2 (9.5) 1 (4.7) 1 (4.7) 7
P. melaninogenica (44) 41 (93.1) 42 (95.4) 1 (2.2) 0 (0.0) 2 (4.4) 5
P. nanceiensisa (13) 0 (0.0) 2 (15.3) 2 (15.3) 1 (7.6) 10 (76.9) 0
P. nigrescens (62) 48 (77.4) 56 (90.3) 8 (90.3) 0 (0.0) 6 (9,6) 6
P. oralis (7) 7 (100) 7 (100) 0 (0.0) 0 (0.0) 0 (0.0) 2
P. oris (16) 16 (100) 16 (100) 0 (0.0) 0 (0.0) 0 (0.0) 3
P. salivae (11) 8 (72.7) 10 (90.9) 2 (18.2) 1 (9.1) 0 (0.0) 3
P. timonensis (9) 5 (55.5) 8 (88.8) 3 (33.3) 0 (0.0) 1 (11.1) 4
P. veroralis (4) 4 (100) 4 (100) 0 (0.0) 0 (0.0) 0 (0.0) 3
Total: 508 (100%) 422 (83.1) 459 (90.4) 37 (7.2) 5 (0.9) 44 (8.6) 67
a Highlighted Prevotella species were missing from the VITEK MS V3.0 database.
Table 2
An overview of the major errors encountered when comparing the identiﬁcation obtained by 16S rRNA gene sequencing and VITEK MS.
Identiﬁcation by 16S rRNA gene sequencing Identiﬁcation by MALDI-TOF MS
P. bergensis Porphyromonas asaccharolytica
P. buccae Peptostreptococcus anaerobius
P. intermediaa Gemella sanguinis/Streptococcus alactolyticus/Pediococcus parvulus
P. nanceiensis Coronobacter sakazakii
P. salivaea Achromobacter denitriﬁcans/S. salivarus/Bacteroides caccae
a Low discrimination multiple genus with 33.3% conﬁdence.
N. Ulger Toprak et al. / Anaerobe xxx (2018) 1e5 3remaining 16 isolates which were not identiﬁed by the MALDI-TOF
MS method during this study, belonged to such Prevotella species,
which were represented in the VITEK MS database, even though
VITEKMSwas not able to identify them. Most of these strains (6/16)
were P. nigrescens.4. Discussion
In this multicenter study, we compared the utility and accuracy
of VITEK MS v3.0 for the identiﬁcation of Prevotella species, us-
ing16S rRNA gene sequencing as the reference method. Initial
studies validating the use of MALDI-TOF MS for the identiﬁcation of
anaerobes reported that <70% of anaerobes could be identiﬁed
[19e21]. However, more recent reports show that the current da-
tabases provide identiﬁcation of >90% of anaerobes [9,22].
In earlier studies, only small numbers of Prevotella isolates
representing different species were tested using MALDI-TOF MS, as
part of the different collections of anaerobic bacteria
[4e6,19,20,23]. So far two studies on identiﬁcation of the Prevotella
species have been conducted. The MALDI Biotyper systemwas used
in both studies and the results were compared with 16S rRNA gene
sequencing. In the ﬁrst study by Wybo et al. in 2012 [14], a total of
102 clinical Prevotella isolates, representing 20 different species,
were tested. Only 62.7% of the isolates were identiﬁed at the species
level and 73.5% at the genus level. Expanding the commercial
database with in-house reference spectra of 23 Prevotella reference
strains and clinical isolates resulted in an increase of correct species
identiﬁcation and genus identiﬁcation of 83.3% and 89.2%, respec-
tively. In the second study by Gursoy et al. [15], the diagnosticPlease cite this article in press as: N. Ulger Toprak, et al., Performance of m
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was tested. Overall, 88.6% of isolates were correctly identiﬁed at the
species level and 100% at the genus level. In the past ﬁve years, the
accuracy of the MALDI Biotyper performance for identifying Pre-
votella species has improved considerably. The most likely expla-
nation for the increased proportion of correct Prevotella
identiﬁcations is the expanded coverage of the MALDI Biotyper
database. The Biotyper database used byWybo et al. [14] contained
20 species, whereas in the second study the database contained 30
Prevotella species [15].
A limited number of studies have been performed in which the
VITEK MS was evaluated for the identiﬁcation of anaerobic bacteria
[10]. The ﬁrst multi-center study evaluation the VITEK MS (v2.0)
systemwas carried out by Garner et al. [24]. A total of 652 anaerobic
clinical isolates were tested including 90 isolates representing ﬁve
different Prevotella species. Broadly speaking, 91.1% of these strains
were correctly identiﬁed at the species level. However, the evalu-
ation of the results inmore detail, the levels of correct identiﬁcation
at the species level for P. intermedia and P. melaninogenica were
81.3% and 54.5%, respectively. Compared to our study, more Pre-
votella strains were identiﬁed at the species level, probably due to
the fact that only ﬁve commonly isolated species were represented.
Our set of strains represented 19 different species, including species
not represented in the database of the VITEK MS. As in our study,
the VITEK MS failed to identify some strains of P. intermedia and
P. melaninogenica, the percentage of correct identiﬁcation at the
species level were 80.9% and 93.1%, respectively. In the other study,
Lee et al. [6] reported only genus level identiﬁcation, misidentiﬁ-
cation or no identiﬁcation for P. buccalis, P. denticola andass spectrometric identiﬁcation of clinical Prevotella species using the
tps://doi.org/10.1016/j.anaerobe.2018.05.016
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lactamase production in 100% of P. melaninogenica and 80% of
P. baroniae species and also showed high rate resistance to tetra-
cycline in these two species with 67% and 20%, respectively. These
results point out that accurate identiﬁcation of Prevotella isolates at
the species level is crucial for initiation of appropriate empirical
antibiotic therapy in case of infections.
In the study by Garner et al. [24] the results of no identiﬁcation
or misidentiﬁcation as mixed genera for P. melaninogenica isolates
were 9.1% or %18.2, respectively. The results for the additional of
12.5% of P. intermedia isolates were classiﬁed as no identiﬁcation. In
our study, the rate of no identiﬁcation for P. melaninogenica and
P. intermedia were 4.4% and 4.7%, respectively. Furthermore, we
noticed that 6 (9.6%) strains of P. nigrescens, and some P. baroniae,
P. buccae, P. denticola, P. timonensis, which would have been rep-
resented in IVD VITEK MS database, were also unidentiﬁed. One
reason for a no identiﬁcation result may be the small number of
main spectra (MSP) in the database. The Reference Library SAP
2436056 IVD VITEK MS contains a total of 67 Prevotella MSPs of 14
Prevotella species. However, two species (one of those P. baroniae)
are represented by a single MSP, and three species represented by
two MSPs for each, which can affect the correct identiﬁcation. This
indicates that the VITEK MS database needs optimization for these
species. Another reason might be the pigmented nature of the or-
ganisms. It has been reported that certain microorganisms, which
have pigments like melanin and other photoactive compoundsmay
hinder the quality of the spectra obtained [25]. 10 of 16 of our
unidentiﬁed isolates, which have MSP in the VITEK MS database,
were pigmented Prevotella species. Our personal experience sug-
gests that identifying pigmented bacteria is more troublesome and
frequently the procedure has to be repeated. However, we have no
investigation of the effect of bacterial pigment on acquired
MALDIeTOF mass spectra, to support this hypothesis.
Five strains in our study were identiﬁed with a major error
(wrong genus); P. bergensis, P. buccae, P. intermedia, P. nanceiensis
and P. salivae. Similar ﬁndings have been reported by Lee et al. [6]
who observed a strain of P. buccalis being misidentiﬁed as Pseu-
doﬂavonifractor capillosus, using VITEK MS. The antimicrobial sus-
ceptibility patterns may markedly be different between genera
even between species. Since the resistance to penicillin has been
reported in about half of Prevotella spp., in our case, use of penicillin
on Prevotella isolates misidentiﬁed as P. anaerobius, Gemella or
Pediococcus, which mostly susceptible to penicillin, may cause
failure of empirical treatment [12,26,27]. Also, for these species,
optimization of the VITEKMS database is recommended, in order to
prevent misidentiﬁcation, thereby enabling selection of the most
appropriate antibacterial therapy and reducing morbidity and
mortality.
This is the ﬁrst study assessing the applicability of the VITEK MS
for the identiﬁcation of human clinical Prevotella that uses an
extensive set of isolates covering 19 different species. In general,
the VITEK MS system performed well in the identiﬁcation of clin-
ically important, frequently found Prevotella strains. However, the
VITEK MS database needs to be expanded and optimized by adding
reference spectra of species not yet represented and of species
underrepresented in the database. Accurate and easy identiﬁcation
of clinical isolates increases interest in studies dealing with
anaerobic organisms, and improves our knowledge of clinical
relevance, epidemiology and the pathogenicity of Prevotella
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